×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

¡¾Ò»ÆÚÒ»»á¡¿ÇïÔϹ²Æ× ¡¤ 10Ô·å»á¾Û½¹ | Where Innovation and Autumn Converge

2025-09-22
|
»á¼ûÁ¿£º

Tips

Ê®ÔÂ×ðÁú¿­Ê±½«Ö÷Àí2³¡ÏßÉÏÖ±²¥£¬Í¬Ê±¼ÓÈë5³¡ÍâÑó¾Û»á£¬ÎÒÃÇÕæÖ¿Ô¼ÇëÄúÏßÉÏÏßÏÂÆë¾Û£¬ÔÚÍ·ÄԻ𻨵ÄÅöײÖУ¬¹²Ì½Ò©ÎïÑз¢µÄÇ°ÑØ¶´²ìÓëδÀ´Ö®Â· ¡£

×ðÁú¿­Ê±ÏßÉÏÖ±²¥Ô¤¸æ
10ÔÂ16ÈÕ£¬Ðì·½Ãû ¶¾ÀíÑо¿²¿¸ß¼¶Ñо¿Ô±
10ÔÂ30ÈÕ£¬Íõ½Ôµ¤ ÖÊÁ¿°ü¹Ü²¿³£ÎñÈÏÕæÈË
×ðÁú¿­Ê±ÏßϲλáÔ¤¸æ
01  
2025/9/30-10/2£¬Messe Basel, Switzerland

Festival of Biologics 2025

Festival of Biologics 2025.webp

30 September - 2 October, 2025
Hall 1, Messe Basel

Dr. Wei Hu will be attending the Festival of Biologics 2025 in Basel and looks forward to meeting with you there. As Europe's premier gathering for antibody discovery, protein engineering, and biotherapeutic development, the festival offers an exceptional environment for forging strategic partnerships, sharing cutting-edge research, and exploring innovative technologies. Dr. Hu will be available throughout the event to discuss how our integrated services and expertise can advance your biolog pipelines - from early discovery through development.

02  
2025/10/10-11£¬¹ãÖÝÏãá°¹ÙÖÞÂùÝ

BIOCHINA»ªÄÏ

BIOCHINA»ªÄÏ.webp

2025Äê10ÔÂ10-11ÈÕ
¹ãÖÝÏãá°¹ÙÖÞÂùÝ
×ðÁú¿­Ê±Õ¹Î» #S43

2025BIOCHINA»ªÄϽ«ÓÚ10ÔÂ10-11ÈÕÔÚ¹ãÖÝÉúÎﵺÏãá°ÂùݾÙÐУ¬´ó»á¶¨Î»¹ãÖÝÁýÕÖ»ªÄÏ£¬Ô¼Çë3000+²Î»á´ú±í£¬±ê¸ËÆóÒµÔÆ¼¯£¬»ã¾Û150+Ç°ÑØ¿ÆÑÐר¼ÒÓëÃôÈñͶ×ÊÈË£¬¹²»°´ÓÊÖÒÕÍ»ÆÆµ½¹¤ÒµÂ䵨µÄÒªº¦Â·¾¶£¬ÉèÖÃ13´óÖ÷ÌâÂÛ̳£¬70+ÄÚÈÝ·ÖÏí£¬º­¸Ç¿¹ÌåÒ©Îï & XDC¡¢Ï¸°ûÖÎÁÆ¡¢ºËËáÒ©Îï¡¢»ùÒòÖÎÁÆ¡¢¶àëÄÒ©ÎС·Ö×ÓÒ©Îï¡¢ÍâÃÚÌåÒ©ÎïµÈ ¡£ÂÛÌ³ÌØÉèAI+Ò©Î↑·¢°å¿é£¬½ÒÃÜÀàÆ÷¹Ù+AI¡¢DEL+AI¡¢¿¹Ìå+AIµÈÇ°ÑØ½»Ö¯ÁìÓòµÄЭͬʵÁ¦ ¡£Í¬Ê±£¬Á¬Ïµ´óÍåÇøÌØÉ«£¬ÐÂÔöÁËÉúÎïÖÆÔì°å¿é£¬½âËøºÏ³ÉÉúÎïѧÔÚÒ½Ò©¡¢Ê³Îï¡¢ÐÂÖÊÁÏ¡¢Ò½ÃÀµÈÁìÓòµÄÖØ´óDZÄÜÓëÉÌÒµÔ¶¾° ¡£

×ðÁú¿­Ê±ÁÙ´²Ç°Ñо¿¸±×ܲÃÔøÏܳɲ©Ê¿½«³öϯԲ×ÀÌÖÂÛ£ºGLP-1¾ºÕùÃûÌÃÓëÁ¢ÒìͻΧ֮· ¡£
×ðÁú¿­Ê±ÍŶӽ«ÔÚÏÖ³¡È«³ÌÉèÕ¹£¬³ÏÑûÄúݰÁÙÏÖ³¡½»Á÷£¡

03  
2025/10/15-18£¬±±¾©¹ú²â¹ú¼Ê»áÕ¹ÖÐÐÄ

µÚÊ®Æß½ì¹ú¼Ê¶¾Àíѧ´ó»á£¨ICTXVII£¬ICT2025£©

µÚÊ®Æß½ì¹ú¼Ê¶¾Àíѧ´ó»á.webp

2025Äê10ÔÂ15-18ÈÕ
±±¾©¹ú²â¹ú¼Ê»áÕ¹ÖÐÐÄ
×ðÁú¿­Ê±Õ¹Î» #N-43

´ó»á½«Ô¼ÇëÀ´×Ô60Óà¸ö¹ú¼Ò/×éÖ¯µÄ¶¾ÀíѧÏà¹ØÁìÓò×ÅÃûר¼Ò£¬È«ÐÄÉèÖÃ42¸öרÌâ·Ö»á³¡¼°×êÑлᣨworkshop£©£»Í¬Ê±£¬»¹ÌØÉè6¸öÅàѵ¿Î³Ì£¬ÒÔ¼°±Ú±¨½»Á÷¡¢¿Æ¼¼Õ¹ÀÀµÈ¶àÖÖ»¥¶¯ÐÎʽ£¬ÎªÓë»áÕߴÁËÒ»¸öÈ«·½Î»¡¢¶àά¶ÈµÄ½»Á÷ƽ̨ ¡£Õâ²»µ«½«¼«´óµØ¸»ºñ¶¾ÀíѧµÄÀíÂÛϵͳ£¬¸ü½«ÓÐÁ¦Íƶ¯ÆäÁ¢ÒìÉú³¤£¬Îª¿µ½¡¿Æ¼¼Ó빤ҵµÄÅÉú³¤×¢ÈëÇ¿¾¢¶¯Á¦ ¡£

´ó»áµÄÒéÌâ°üÀ¨£¨µ«²»ÏÞÓÚ£©ÇéÐζ¾Àíѧ¡¢ÄÉÃ×¶¾Àíѧ¡¢ÁÙ´²¶¾Àíѧ¡¢±í¹ÛÒÅ´«¶¾Àíѧ¡¢ÉúÎﻯѧºÍ·Ö×Ó¶¾Àíѧ¡¢¹¤Òµ¶¾ÀíѧºÍ»¯Ñ§ËðÉË¡¢ÆÊÎö¶¾Àíѧ¡¢ÒÅ´«¶¾ÐÔºÍÖ°©ÐÔÆÀ¹À¡¢ÖؽðÊô¶¾ÐÔ¼°ÆäÏà¹Ø¼²²¡¡¢ÅÌËã¶¾Àíѧ¡¢°ÐÆ÷¹Ù¶¾ÐÔ¼°Æä·Ö×Ó»úÖÆ¡¢Ò©ÎïºÍʳÎïÇå¾²¼°Î£º¦ÆÀ¹À¡¢ÖÐÒ©ºÍ×ÔȻҩÎïµÄ¶¾Àíѧ¡¢Ìæ»»¶¾ÀíѧҪÁì¡¢ÏÂÒ»´úΣº¦ÆÀ¹À£¨NGRA£©¡¢ÐÂÒªÁìѧ£¨NAMs£©¼°ÆäÔÚ¶¾ÀíѧÖеÄÓ¦Óá¢ÐÂÄÜÔ´µÄÇå¾²ÐÔÆÀ¹À¡¢´óÊý¾ÝºÍÈ˹¤ÖÇÄÜ¡¢Æ÷¹ÙоƬºÍ3D´òÓ¡¡¢¶¾ÀíѧÓë¶¾Îï×éѧ¡¢¸ßͨÁ¿ÆÊÎö¡¢¶¾ÐÔ;¾¶ºÍ²»Á¼Ð§¹û;¾¶µÈ ¡£

×ðÁú¿­Ê±Ê×ϯ¿ÆÑ§¹ÙÅíË«Çå½ÌÊÚ½«³öϯ²¢µ£µ±ÂÛ̳Ö÷³ÖÈË£¬¶¾ÀíÑо¿²¿¸ß¼¶Ö÷ÈÎÔ·ÏþÑ಩ʿ½«³öϯ²¢·¢Ñݳö½² ¡£
×ðÁú¿­Ê±ÍŶӽ«ÔÚÏÖ³¡È«³ÌÉèÕ¹£¬³ÏÑûÄúݰÁÙÏÖ³¡½»Á÷£¡

04  
2025/10/17-19£¬ÉϺ£ºÃÍû½ÇÂùÝ

2025Öйúҩѧ»áÖÇÄÜÒ©ÎïרҵίԱ»áѧÊõÄê»á

2025Öйúҩѧ»áÖÇÄÜÒ©ÎïרҵίԱ»áѧÊõÄê»á.webp

2025Äê10ÔÂ17-19ÈÕ
ÉϺ£ºÃÍû½ÇÂùÝ

¾Û»á½«Ô¼Çë¸ßµÈԺУ¡¢¿ÆÑÐÔºËù¡¢Ò½ÁÆ»ú¹¹¡¢ÖÆÒ©ÆóÒµ¡¢ÖÎÀí»ú¹¹µÈ×ÅÃûר¼Ò×öÖ÷Ìⱨ¸æºÍרÌâ×êÑУ¬¾Û½¹È˹¤ÖÇÄÜÇý¶¯µÄÒ©Îï·¢Ã÷¡¢ÖÇÄܵÝËÍϵͳ¡¢ÁÙ´²¾öÒéÖ§³Ö¹¤¾ß¡¢¸öÐÔ»¯ÖÎÁƼƻ®µÈÁìÓòµÄÍ»ÆÆÐÔÏ£Íû£¬Ì½ÌÖÖÇÄÜÒ©ÎïÔÚÖ×Áö¡¢Éñ¾­ÏµÍ³¼²²¡¡¢ÓÐÊý²¡µÈÁÙ´²³¡¾°ÖеÄת»¯Ç±Á¦ÓëÌôÕ½£¬ÅäºÏÍÆ¶¯ÖÇÄÜÒ©ÎïÁìÓòµÄ²ýÊ¢Éú³¤£¬ÎªÈËÀàµÄ¿µ½¡ÊÂҵТ˳ÖÇ»ÛÓëʵÁ¦ ¡£

×ðÁú¿­Ê±¿ÆÑÐר¼Ò½«³öϯ±¾´Î¾Û»á²¢Ðû²¼Ñݽ² ¡£

05  
2025/10/30-31£¬Jeju Island£¬South Korea

KSNS 2025

KSNS 2025.webp

KSNS 2025 - The Korean Society of Nonclinical Study
October 30-31, 2025
International Convention Center Jeju Jeju Island

Medicilon invites you to meet our team at KSNS 2025 - The Korean Society of Nonclinical Study. Our representatives will include Dr. Jinna Cai (CBO), Dr. Hanjun Zou (TFM), and Mr. Junhong Xu (VP, Business Development). We are especially pleased to announce that Dr. Hanjun Zou will deliver a Lunch Seminar presentation entitled: ¡°An Overview of Medicilon Preclinical Research and Case Studies in Monkey¡±. Visit our booth to discuss your nonclinical research needs and discover how Medicilon's comprehensive toxicology services (GLP and non-GLP) can support your drug development. As a leading CRO, Medicilon provides extensive R&D solutions for global pharmaceutical companies, emerging biotech companies, and research institutions. Medicilon Experience for Filing of INDWith over 20 years of experience, we have supported more than 2,000 clients and contributed to the IND approval of over 580 drugs. We look forward to exploring collaboration opportunities with you at KSNS 2025.

ɨÂëÁªÏµ.webp
   marketing@medicilon.com
ýÌåÓë»áÎñÇëÁªÏµ
×ðÁú¿­Ê±Êг¡²¿Î¢ÐÅ»òÓÊÏä

Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿